• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

估算针对新冠病毒感染的中和抗体的衰减曲线。

Estimating decay curves of neutralizing antibodies to SARS-CoV-2 infection.

作者信息

Poehler Elliot, Gibson Liam, Lustig Audrey, Moreland Nicole J, McGregor Reuben, James Alex

机构信息

School of Mathematics and Statistics, University of Canterbury, Christchurch, New Zealand.

Te Pūnaha Matatini: the Centre for Complex Systems and Networks, Auckland, New Zealand.

出版信息

Math Med Biol. 2022 Dec 2;39(4):368-381. doi: 10.1093/imammb/dqac008.

DOI:10.1093/imammb/dqac008
PMID:35759280
Abstract

Estimating the longevity of an individual's immune response to the SARS-Cov-2 virus is vital for future planning, particularly of vaccine requirements. Neutralizing antibodies (Nabs) are increasingly being recognized as a correlate of protection and while there are many studies that follow the response of a cohort of people, each study alone is not enough to predict the long-term response. Studies use different assays to measure Nabs, making them hard to combine. We present a modelling method that can combine multiple datasets and can be updated as more detailed data becomes available. Combining data from seven published datasets we predict that the NAb decay has two phases, an initial fast but short-lived decay period followed by a longer term and slower decay period.

摘要

评估个体对新冠病毒免疫反应的持续时间对于未来规划至关重要,尤其是在疫苗需求方面。中和抗体(Nabs)越来越被认为是一种保护相关性,虽然有许多研究跟踪一群人的反应,但每项单独的研究都不足以预测长期反应。研究使用不同的检测方法来测量中和抗体,这使得它们难以合并。我们提出了一种建模方法,该方法可以合并多个数据集,并可以在获得更详细的数据时进行更新。结合来自七个已发表数据集的数据,我们预测中和抗体的衰减有两个阶段,一个初始快速但短暂的衰减期,随后是一个长期且较慢的衰减期。

相似文献

1
Estimating decay curves of neutralizing antibodies to SARS-CoV-2 infection.估算针对新冠病毒感染的中和抗体的衰减曲线。
Math Med Biol. 2022 Dec 2;39(4):368-381. doi: 10.1093/imammb/dqac008.
2
Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China.评估中国上海轻症 COVID-19 康复患者临床特征与中和抗体水平的相关性。
JAMA Intern Med. 2020 Oct 1;180(10):1356-1362. doi: 10.1001/jamainternmed.2020.4616.
3
Simultaneous measurement of multiple variant-specific SARS-CoV-2 neutralizing antibodies with a multiplexed flow cytometric assay.使用多重流式细胞术检测试剂盒同时测量多种变异特异性 SARS-CoV-2 中和抗体。
Front Immunol. 2022 Nov 25;13:1039163. doi: 10.3389/fimmu.2022.1039163. eCollection 2022.
4
Neutralizing Monoclonal Antibodies Inhibit SARS-CoV-2 Infection through Blocking Membrane Fusion.中和单克隆抗体通过阻断膜融合抑制 SARS-CoV-2 感染。
Microbiol Spectr. 2022 Apr 27;10(2):e0181421. doi: 10.1128/spectrum.01814-21. Epub 2022 Mar 16.
5
Evaluation of a rapid semiquantitative lateral flow assay for the prediction of serum neutralizing activity against SARS-CoV-2 variants.评估一种快速半定量侧向流动测定法,用于预测针对 SARS-CoV-2 变体的血清中和活性。
J Clin Virol. 2022 Oct;155:105268. doi: 10.1016/j.jcv.2022.105268. Epub 2022 Aug 17.
6
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2.辉瑞-BioNTech 两剂疫苗接种后 COVID-19 患者和疫苗接种者的中和抗体。
Viruses. 2021 Jul 14;13(7):1364. doi: 10.3390/v13071364.
7
SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates against Symptomatic Infection.SARS-CoV-2 恢复期血清的结合和中和抗体浓度与 COVID-19 疫苗对有症状感染的疗效估计值比较。
Microbiol Spectr. 2022 Aug 31;10(4):e0124722. doi: 10.1128/spectrum.01247-22. Epub 2022 Jul 20.
8
Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients.新冠病毒感染后 S1 IgG 和中和抗体的产生和持续时间。
Infection. 2022 Apr;50(2):447-456. doi: 10.1007/s15010-021-01705-7. Epub 2021 Oct 19.
9
Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.COVID-19 患者症状出现后七个月内 SARS-CoV-2 特异性和中和抗体的动力学。
Microbiol Spectr. 2021 Oct 31;9(2):e0059021. doi: 10.1128/Spectrum.00590-21. Epub 2021 Sep 22.
10
SARS-CoV-2-Specific Adaptive Immunity in COVID-19 Survivors With Asthma.COVID-19 幸存者哮喘患者中的 SARS-CoV-2 特异性适应性免疫。
Front Immunol. 2022 Jul 18;13:947724. doi: 10.3389/fimmu.2022.947724. eCollection 2022.

引用本文的文献

1
Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study.青少年在整个 COVID-19 大流行期间持续存在体液免疫反应:基于学校的前瞻性队列研究。
Nat Commun. 2023 Nov 27;14(1):7764. doi: 10.1038/s41467-023-43330-y.
2
Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort.基于人群的队列研究中,SARS-CoV-2 感染后具有不同轨迹的异质性体液和细胞免疫反应。
Nat Commun. 2022 Aug 18;13(1):4855. doi: 10.1038/s41467-022-32573-w.